“…Various human diseases including obesity, diabetes, and Alzheimer’s disease are associated with changes in the cellular lipidome. − Cancer is another pathology that is adept at increasing cellular uptake and de novo synthesis of lipids in order to maintain rapid cell proliferation. − Consequently, detailed structural characterization of lipids in extracts from cancer cells and tissues is increasingly desirable and requires molecular identification based on lipid class, number of carbons and double bonds (sum composition), relative ( sn -) position of fatty acyl chains in glycerolipids, and the position of functional groups on fatty acyl chains (e.g., unsaturation, methylation, or hydroxylation). Establishing the sites(s) of unsaturation within glycerophospholipids has been a recent focus in cancer lipidomics due to observations of perturbations in desaturation and elongation metabolism , that may potentiate downstream impacts on membrane biophysical properties (e.g., lipid membrane fluidity). , Determining the position(s) of carbon–carbon double bonds is thus central to understanding the variability of human lipid metabolism in health and disease; particularly those pathways involving the expression and activity of the three mammalian desaturase enzymes SCD-1, FADS1, and FADS2. , Notably, changes in the relative abundance of n- 7 and n- 9 double bond isomers in glycerophospholipids have been found to be phenotypic of cancer, − while the recent observation of n- 10 double bonds in some cancers is evidence for activation of FADS2 metabolism toward saturated fatty acids; a process first thought to be confined to human skin. ,− Such discoveries have reinvigorated efforts to develop mass spectrometric techniques capable of assigning double bond position(s) in glycerophospholipids (and other lipid classes).…”